Literature DB >> 17241657

Effects of UMB24 and (+/-)-SM 21, putative sigma2-preferring antagonists, on behavioral toxic and stimulant effects of cocaine in mice.

Rae R Matsumoto1, Buddy Pouw, Aisha L Mack, Antawan Daniels, Andrew Coop.   

Abstract

Earlier studies have demonstrated that antagonism of sigma1 receptors attenuates the convulsive, lethal, locomotor stimulatory and rewarding actions of cocaine in mice. In contrast, the contribution of sigma2 receptors is unclear because experimental tools to selectively target this subtype are unavailable. To begin addressing this need, we characterized UMB24 (1-(2-phenethyl)-4-(2-pyridyl)-piperazine) and (+/-)-SM 21 (3alpha-tropanyl-2-(4-chorophenoxy)butyrate) in receptor binding and behavioral studies. Receptor binding studies confirmed that UMB24 and (+/-)-SM 21 display preferential affinity for sigma2 over sigma1 receptors. In behavioral studies, pretreatment of Swiss Webster mice with UMB24 or (+/-)-SM 21 significantly attenuated cocaine-induced convulsions and locomotor activity, but not lethality. When administered alone, (+/-)-SM 21 produced no significant effects compared to control injections of saline, but UMB24 had locomotor depressant actions. Together, the data suggest that sigma2 receptor antagonists have the potential to attenuate some of the behavioral effects of cocaine, and further development of more selective, high affinity ligands are warranted.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17241657      PMCID: PMC1892169          DOI: 10.1016/j.pbb.2006.12.011

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  30 in total

1.  The analgesic tropane analogue (+/-)-SM 21 has a high affinity for sigma2 receptors.

Authors:  R H Mach; L Wu; T West; B R Whirrett; S R Childers
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

2.  Novel spiropiperidines as highly potent and subtype selective sigma-receptor ligands. Part 1.

Authors:  Christoph A Maier; Bernhard Wünsch
Journal:  J Med Chem       Date:  2002-01-17       Impact factor: 7.446

3.  Synthesis and in vivo evaluation of a new PET radioligand for studying sigma-2 receptors.

Authors:  Michael Kassiou; Robert F Dannals; Xiang Liu; Dean F Wong; Hayden T Ravert; Ursula A Scheffel
Journal:  Bioorg Med Chem       Date:  2005-06-01       Impact factor: 3.641

Review 4.  Cocaine, reward, movement and monoamine transporters.

Authors:  G R Uhl; F S Hall; I Sora
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

5.  Modulation of cellular calcium by sigma-2 receptors: release from intracellular stores in human SK-N-SH neuroblastoma cells.

Authors:  B J Vilner; W D Bowen
Journal:  J Pharmacol Exp Ther       Date:  2000-03       Impact factor: 4.030

6.  (+/-)-SM 21 attenuates the convulsive and locomotor stimulatory effects of cocaine in mice.

Authors:  R R Matsumoto; A L Mack
Journal:  Eur J Pharmacol       Date:  2001-04-06       Impact factor: 4.432

7.  Rimcazole analogs attenuate the convulsive effects of cocaine: correlation with binding to sigma receptors rather than dopamine transporters.

Authors:  R R Matsumoto; K L Hewett; B Pouw; W D Bowen; S M Husbands; J J Cao; A H Newman
Journal:  Neuropharmacology       Date:  2001-12       Impact factor: 5.250

8.  Synthesis of N-substituted 9-azabicyclo[3.3.1]nonan-3alpha-yl carbamate analogs as sigma2 receptor ligands.

Authors:  Suwanna Vangveravong; Jinbin Xu; Chenbo Zeng; Robert H Mach
Journal:  Bioorg Med Chem       Date:  2006-07-11       Impact factor: 3.641

9.  Cocaine-induced convulsions: pharmacological antagonism at serotonergic, muscarinic and sigma receptors.

Authors:  M C Ritz; F R George
Journal:  Psychopharmacology (Berl)       Date:  1997-02       Impact factor: 4.530

10.  Pharmacological identification of SM-21, the novel sigma(2) antagonist.

Authors:  C Ghelardini; N Galeotti; A Bartolini
Journal:  Pharmacol Biochem Behav       Date:  2000-11       Impact factor: 3.533

View more
  21 in total

1.  The effect of the pyridyl nitrogen position in pyridylpiperazine sigma ligands.

Authors:  Lidiya Stavitskaya; Michael J Seminerio; Marilyn M Matthews-Tsourounis; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2010-03-01       Impact factor: 2.823

2.  Nitrile analogs of meperidine as high affinity and selective sigma-1 receptor ligands.

Authors:  Susan L Mercer; Jamaluddin Shaikh; John R Traynor; Rae R Matsumoto; Andrew Coop
Journal:  Eur J Med Chem       Date:  2007-10-06       Impact factor: 6.514

3.  Sigma1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice.

Authors:  J Kitanaka; N Kitanaka; T Tatsuta; F S Hall; G R Uhl; K Tanaka; N Nishiyama; Y Morita; M Takemura
Journal:  Psychopharmacology (Berl)       Date:  2008-12-04       Impact factor: 4.530

4.  Ethanol-related behaviors in mice lacking the sigma-1 receptor.

Authors:  Marta Valenza; Alyssa DiLeo; Luca Steardo; Pietro Cottone; Valentina Sabino
Journal:  Behav Brain Res       Date:  2015-10-14       Impact factor: 3.332

5.  Chlorophenylpiperazine analogues as high affinity dopamine transporter ligands.

Authors:  William C Motel; Jason R Healy; Eddy Viard; Buddy Pouw; Kelly Martin; Rae R Matsumoto; Andrew Coop
Journal:  Bioorg Med Chem Lett       Date:  2013-10-15       Impact factor: 2.823

6.  Selective reduction of alcohol drinking in Sardinian alcohol-preferring rats by a sigma-1 receptor antagonist.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Luca Steardo; George F Koob; Eric P Zorrilla
Journal:  Psychopharmacology (Berl)       Date:  2009-05-14       Impact factor: 4.530

7.  Cocaine occupancy of sigma1 receptors and dopamine transporters in mice.

Authors:  John R Lever; Emily A Fergason-Cantrell; Lisa D Watkinson; Terry L Carmack; Sarah A Lord; Rong Xu; Dennis K Miller; Susan Z Lever
Journal:  Synapse       Date:  2015-12-24       Impact factor: 2.562

8.  The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism.

Authors:  Melanie A Paquette; Katherine Foley; Elizabeth G Brudney; Charles K Meshul; Steven W Johnson; S Paul Berger
Journal:  Psychopharmacology (Berl)       Date:  2009-03-13       Impact factor: 4.530

9.  The sigma-receptor antagonist BD-1063 decreases ethanol intake and reinforcement in animal models of excessive drinking.

Authors:  Valentina Sabino; Pietro Cottone; Yu Zhao; Malliga R Iyer; Luca Steardo; Luca Steardo; Kenner C Rice; Bruno Conti; George F Koob; Eric P Zorrilla
Journal:  Neuropsychopharmacology       Date:  2008-10-22       Impact factor: 7.853

10.  Pharmacology and therapeutic potential of sigma(1) receptor ligands.

Authors:  E J Cobos; J M Entrena; F R Nieto; C M Cendán; E Del Pozo
Journal:  Curr Neuropharmacol       Date:  2008-12       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.